[HTML][HTML] S100 proteins as novel therapeutic targets in psoriasis and other autoimmune diseases

K Kurpet, G Chwatko - Molecules, 2022 - mdpi.com
Psoriasis is one of the most common inflammatory skin diseases affecting about 1–3% of the
population. One of the characteristic abnormalities in psoriasis is the excessive production of …

Exploring the potential of nanocarriers in antipsoriatic therapeutics

M Shaif, P Kushwaha, S Usmani… - Journal of Dermatological …, 2022 - Taylor & Francis
Psoriasis is an autoimmune disease characterized by erythematous, scaly patches on the
skin. It can be effectively managed with topical therapies since they deliver drugs to target …

[HTML][HTML] Mechanical stretch exacerbates psoriasis by stimulating keratinocyte proliferation and cytokine production

P Qiao, W Guo, Y Ke, H Fang, Y Zhuang… - Journal of Investigative …, 2019 - Elsevier
Psoriasis is a chronic inflammatory autoimmune skin disease that often occurs in rubbed
areas undergoing a strong mechanical stretch, such as the elbows and knees. However, the …

Topical turmeric microemulgel in the management of plaque psoriasis; a clinical evaluation

G Sarafian, M Afshar, P Mansouri… - Iranian journal of …, 2015 - pmc.ncbi.nlm.nih.gov
Psoriasis is an autoimmune and recurrent chronic inflammatory skin disease. About 1-3% of
the world wide populations are affected. The characteristic features are hyperprolifration of …

Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis

H Jain, D Geetanjali, H Dalvi, A Bhat, C Godugu… - Journal of Drug Delivery …, 2022 - Elsevier
Psoriasis is an autoimmune dermal disorder characterized by the emergence of red patches,
scaling and does not have any proficient therapeutic option. The study involves the …

Jojoba oil soft colloidal nanocarrier of a synthetic retinoid: preparation, characterization and clinical efficacy in psoriatic patients

M Nasr, S Abdel-Hamid, N H. Moftah… - Current drug …, 2017 - benthamdirect.com
Background: Nanotechnology has provided substantial benefits in drug delivery, especially
in the treatment of dermatological diseases. Psoriasis is a chronic inflammatory skin disease …

[HTML][HTML] Psoriasis, Is It a Microdamage of Our “Sixth Sense”? A Neurocentric View

B Sonkodi - International Journal of Molecular Sciences, 2022 - mdpi.com
Psoriasis is considered a multifactorial and heterogeneous systemic disease with many
underlying pathologic mechanisms having been elucidated; however, the pathomechanism …

Impact of quercetin spanlastics on livin and caspase-9 expression in the treatment of psoriasis vulgaris

AU Ali, ISA Khallaf, AA Kamel, AY Badran… - Journal of Drug Delivery …, 2022 - Elsevier
Psoriasis is a chronic immune-mediated disease presented by erythematic lesions. It is an
incurable disease; however, topical treatment attempts to stop the uncontrolled proliferation …

PsLSNetV2: End to end deep learning system for measurement of area score of psoriasis regions in color images

R Raj, ND Londhe, R Sonawane - Biomedical Signal Processing and …, 2023 - Elsevier
Objective At present, psoriasis area scores are measured manually by dermatologists
through visual observations. This subjective method suffers from numerous typical problems …

An overview on promising nanotechnological approaches for the treatment of psoriasis

K Pandey - Recent Patents on Nanotechnology, 2020 - ingentaconnect.com
Background: Psoriasis is a chronic autoimmune disorder of the skin which is characterized
by the reoccurring episodes of inflammatory lesions with a worldwide occurrence of around …